GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Innova Captab Ltd (BOM:544067) » Definitions » Price-to-Owner-Earnings

Innova Captab (BOM:544067) Price-to-Owner-Earnings : 83.72 (As of Jun. 01, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Innova Captab Price-to-Owner-Earnings?

As of today (2025-06-01), Innova Captab's share price is ₹876.60. Innova Captab's Owner Earnings per Share (TTM) ended in Mar. 2025 was ₹10.47. It's Price-to-Owner-Earnings for today is 83.72.


The historical rank and industry rank for Innova Captab's Price-to-Owner-Earnings or its related term are showing as below:

BOM:544067' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 43.66   Med: 46.09   Max: 59.14
Current: 59.14

During the past 7 years, the highest Price-to-Owner-Earnings of Innova Captab was 59.14. The lowest was 43.66. And the median was 46.09.


BOM:544067's Price-to-Owner-Earnings is ranked worse than
81.25% of 448 companies
in the Drug Manufacturers industry
Industry Median: 25.175 vs BOM:544067: 59.14

As of today (2025-06-01), Innova Captab's share price is ₹876.60. Innova Captab's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹22.40. Therefore, Innova Captab's PE Ratio (TTM) for today is 39.13.

As of today (2025-06-01), Innova Captab's share price is ₹876.60. Innova Captab's EPS without NRI for the trailing twelve months (TTM) ended in was ₹22.40. Therefore, Innova Captab's PE Ratio without NRI for today is 39.13.

During the past 7 years, Innova Captab's highest PE Ratio without NRI was 48.42. The lowest was 24.48. And the median was 35.97.


Innova Captab Price-to-Owner-Earnings Historical Data

The historical data trend for Innova Captab's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innova Captab Price-to-Owner-Earnings Chart

Innova Captab Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - 42.84 -

Innova Captab Quarterly Data
Mar19 Mar20 Mar21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.84 - - - -

Competitive Comparison of Innova Captab's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Innova Captab's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innova Captab's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Innova Captab's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Innova Captab's Price-to-Owner-Earnings falls into.


;
;

Innova Captab Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Innova Captab's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=876.60/10.47
=83.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Innova Captab  (BOM:544067) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Innova Captab Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Innova Captab's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Innova Captab Business Description

Traded in Other Exchanges
Address
SCO No. 301, Sector 9, Second Floor, Panchkula, HR, IND, 134109
Innova Captab Ltd is an integrated pharmaceutical company in India and is engaged in research and development, manufacturing, drug distribution, and marketing and exports. Company business includes (i) a contract development and manufacturing organization ("CDMO") business providing manufacturing services to Indian pharmaceutical companies, (ii) a domestic branded generics business, and (iii) an international branded generics business.

Innova Captab Headlines

No Headlines